The Biocollective Patents – Insights & Stats (Updated 2023)

The Biocollective has a total of 5 patents globally, out of which 4 have been granted. Of these 5 patents, more than 60% patents are active. United States of America is where The Biocollective has filed the maximum number of patents, followed by Europe and United Kingdom. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of The Biocollective.

The Biocollective was founded in the year 2015. The Company is an innovation engine for the microbiome providing for contextual solutions to improving health.

Do read about some of the most popular patents of The Biocollective which have been covered by us in this article and also you can find The Biocollective patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over The Biocollective patent portfolio.

How many patents does the founder and the CEO of The Biocollective have?

The founder and CEO Martha Carlin has 0 patent.

How many patents does The Biocollective have?

The Biocollective has a total of 5 patents globally. These patents belong to 2 unique patent families. Out of 5 patents, 3 patents are active.

How Many Patents did The Biocollective File Every Year?

The Biocollective Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantThe Biocollective Applications FiledThe Biocollective Patents Granted
20231
201821
201632

How many The Biocollective patents are Alive/Dead?

The Biocollective Patent Portfolio

 How Many Patents did The Biocollective File in Different Countries?

The Biocollective Worldwide Patent Filing

Countries in which The Biocollective Filed Patents

CountryPatents
United States Of America2
Europe1
United Kingdom1

Where are Research Centres of The Biocollective Patents Located?

The Research Centre for all the The Biocollective patents is the United States of America.

What Percentage of The Biocollective US Patent Applications were Granted?

The Biocollective (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.

Below are the key stats of The Biocollective patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for The Biocollective?

Law FirmTotal ApplicationsSuccess Rate
Howson & Howson Llp10%

List of The Biocollective Patents

The Biocollective PatentsTitle
US11850270B2Probiotics And Methods Of Use
USD807500S1Biological Collection Device
GB90033032960001SReceptacles [Medical]
WO2019113023A9Probiotics And Methods Of Use
EU0033032960001SReceptacles [Medical]

What are The Biocollective key innovation segments?

What Technologies are Covered by The Biocollective?

The chart below distributes patents filed by The Biocollective in different countries on the basis of the technology protected in patents. It also represents the markets where The Biocollective thinks it’s important to protect particular technology inventions.

R&D Focus: How has The Biocollective search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by The Biocollective?

Related Articles

Xiamen Easo Patents – Insights & Stats (Updated 2024)

Xiamen Easo has a total of 681 patents globally, out of which 536 have been granted. Of these 681 patents, more than 59% patents are active. China is where Xiamen Easo has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.